Pegasta 6mg Injection

Product Description

Pegasta 6mg Injectionis prescribed for the treatment of abnormally low white blood cell count, fever and infection due to neutropenia in patients receiving chemotherapy, chronic myeloid leukemia, cancer in which the bone marrow does not make enough healthy blood cells along with several other problems. Pegex Injection contains the salts Pegfilgrastim as active ingredients. It is available in injection form Pegfilgrastim,a synthetic protein, is used to prevent neutropenia due to chemotherapy. The protein stimulates synthesis of white blood cells in the bone marrow, and prevents infections.

Pegfilgrastim is contraindicated in patients with chronic myeloid leukemia, sickle cell disorders, myelodysplastic disorders and latex allergy.

Mechanism of Action

Pegasta 6mg Injection contains Pegfilgrastim, which stimulates the bone marrow to produce more white blood cells. This enhances the body's ability to fight infections during periods of low immunity, such as after chemotherapy. Its reliable formulation makes it suitable for a broad range of patients requiring immune support.


Benefits of Pegasta 6mg Injection

This product significantly lowers the chances of infection and associated complications in immunocompromised patients. By boosting white blood cell count, it allows patients to complete their prescribed treatment regimens with reduced risks and interruptions due to infections.


Usage and Administration

Administer Pegasta 6mg Injection following your doctor's instructions, typically as a single subcutaneous injection. Only qualified healthcare professionals should perform the injection. Regular monitoring is advised to ensure the optimal therapeutic effect and safety.